Iterum Therapeutics Competitors, Revenue, Alternatives and Pricing
Estimated Revenue & Financials
- Iterum Therapeutics's estimated annual revenue is currently $11.9M per year.
- Iterum Therapeutics's estimated revenue per employee is $201,000
- Iterum Therapeutics's total funding is $157M.
- Iterum Therapeutics has 59 Employees.
- Iterum Therapeutics grew their employee count by 16% last year.
- Iterum Therapeutics currently has 2 job openings.
What Is Iterum Therapeutics?
Iterum Therapeutics plc is an Ireland-based clinical-stage pharmaceutical company dedicated to developing differentiated anti-infectives. These products are aimed at combatting the global crisis of multi-drug resistant (MDR) pathogens to significantly improve the lives of people affected by serious and life-threatening diseases around the world. Iterum's first product is a novel anti-infective compound that has demonstrated potent in-vitro activity vs. a wide variety of gram-negative, gram-positive and anaerobic bacteria resistant to other antibiotics. For more information on Iterum Therapeutics please visit www.iterumtx.com.keywords:N/A